Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes
Diabetes-induced kidney cell injury involves an increase in matrix protein expression that is only partly alleviated by current treatment, prompting a search for new modalities. We have previously shown that hydrogen sulfide (H2S) inhibits high glucose-induced protein synthesis in kidney podocytes....
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2015-05, Vol.290 (19), p.12014-12026 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 12026 |
---|---|
container_issue | 19 |
container_start_page | 12014 |
container_title | The Journal of biological chemistry |
container_volume | 290 |
creator | Lee, Hak Joo Feliers, Denis Mariappan, Meenalakshmi M. Sataranatarajan, Kavithalakshmi Choudhury, Goutam Ghosh Gorin, Yves Kasinath, Balakuntalam S. |
description | Diabetes-induced kidney cell injury involves an increase in matrix protein expression that is only partly alleviated by current treatment, prompting a search for new modalities. We have previously shown that hydrogen sulfide (H2S) inhibits high glucose-induced protein synthesis in kidney podocytes. We tested whether tadalafil, a phosphodiesterase 5 inhibitor used to treat erectile dysfunction, ameliorates high glucose stimulation of matrix proteins by generating H2S in podocytes. Tadalafil abrogated high glucose stimulation of global protein synthesis and matrix protein laminin γ1. Tadalafil inhibited high glucose-induced activation of mechanistic target of rapamycin complex 1 and laminin γ1 accumulation in an AMP-activated protein kinase (AMPK)-dependent manner. Tadalafil increased AMPK phosphorylation by stimulating calcium-calmodulin kinase kinase β. Tadalafil rapidly increased the expression and activity of the H2S-generating enzyme cystathionine γ-lyase (CSE) by promoting its translation. dl-Propargylglycine, a CSE inhibitor, and siRNA against CSE inhibited tadalafil-induced AMPK phosphorylation and abrogated the tadalafil effect on high glucose stimulation of laminin γ1. In tadalafil-treated podocytes, we examined the interaction between H2S and nitric oxide (NO). Nω-Nitro-l-arginine methyl ester and 1H-[1,2,4]-oxadiazolo-[4,3-a]-quinoxalin-1-one, inhibitors of NO synthase (NOS) and soluble guanylyl cyclase, respectively, abolished tadalafil induction of H2S and AMPK phosphorylation. Tadalafil rapidly augmented inducible NOS (iNOS) expression by increasing its mRNA, and siRNA for iNOS and 1400W, an iNOS blocker, inhibited tadalafil stimulation of CSE expression and AMPK phosphorylation. We conclude that tadalafil amelioration of high glucose stimulation of synthesis of proteins including matrix proteins in podocytes requires integration of the NO-H2S-AMPK axis leading to the inhibition of high glucose-induced mechanistic target of rapamycin complex 1 activity and mRNA translation.
Background: The mechanism underlying tadalafil regulation of diabetes-induced matrix synthesis in the kidney is unknown.
Results: In podocytes, tadalafil stimulated inducible nitric-oxide synthase to generate hydrogen sulfide and inhibit high glucose-induced matrix protein synthesis.
Conclusion: Tadalafil recruits nitric oxide and hydrogen sulfide to inhibit high glucose-induced matrix protein synthesis.
Significance: Tadalafil may be tested for treating diabetic kidney dis |
doi_str_mv | 10.1074/jbc.M114.615377 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4424338</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820485114</els_id><sourcerecordid>25752605</sourcerecordid><originalsourceid>FETCH-LOGICAL-c489t-77e610d764a7caa2f2b649a36ae0a5c0f354786e15db7426819805db8377f4ae3</originalsourceid><addsrcrecordid>eNp1kU9v3CAQxVHVqtkkPfdW8QW8ARuMfalURU02Uv5JSaXcEIaxdyIHImCj7LWfvESbRu0hXGBg3m_Ee4R85WzJmRJH94NdXnAuli2XjVIfyIKzrqkaye8-kgVjNa_6WnZ7ZD-le1aW6PlnsldLJeuWyQX5fWucmc2IMz3zGaZoMiR6iTmipVfP6KBabV0ME3h6s5nHckFvcPJmRj_RHIpqjQNmusJpTU_njQ0JKvRuY8HRC1M4z_Q6hgxYAFuf15Aw0VJcBxfstkw7JJ9GMyf48rofkF8nP2-PV9X51enZ8Y_zyoquz5VS0HLmVCuMssbUYz20ojdNa4AZadnYSKG6Frh0gxJ12_G-Y-XcFV9GYaA5IN933MfN8ADOgs_RzPox4oOJWx0M6v9fPK71FJ60ELVomq4AjnYAG0NKEcY3LWf6JQ5d4tAvcehdHEXx7d-Rb_1__S8N_a4BysefEKJOFsEX7zCCzdoFfBf-B7ycnQ4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Lee, Hak Joo ; Feliers, Denis ; Mariappan, Meenalakshmi M. ; Sataranatarajan, Kavithalakshmi ; Choudhury, Goutam Ghosh ; Gorin, Yves ; Kasinath, Balakuntalam S.</creator><creatorcontrib>Lee, Hak Joo ; Feliers, Denis ; Mariappan, Meenalakshmi M. ; Sataranatarajan, Kavithalakshmi ; Choudhury, Goutam Ghosh ; Gorin, Yves ; Kasinath, Balakuntalam S.</creatorcontrib><description>Diabetes-induced kidney cell injury involves an increase in matrix protein expression that is only partly alleviated by current treatment, prompting a search for new modalities. We have previously shown that hydrogen sulfide (H2S) inhibits high glucose-induced protein synthesis in kidney podocytes. We tested whether tadalafil, a phosphodiesterase 5 inhibitor used to treat erectile dysfunction, ameliorates high glucose stimulation of matrix proteins by generating H2S in podocytes. Tadalafil abrogated high glucose stimulation of global protein synthesis and matrix protein laminin γ1. Tadalafil inhibited high glucose-induced activation of mechanistic target of rapamycin complex 1 and laminin γ1 accumulation in an AMP-activated protein kinase (AMPK)-dependent manner. Tadalafil increased AMPK phosphorylation by stimulating calcium-calmodulin kinase kinase β. Tadalafil rapidly increased the expression and activity of the H2S-generating enzyme cystathionine γ-lyase (CSE) by promoting its translation. dl-Propargylglycine, a CSE inhibitor, and siRNA against CSE inhibited tadalafil-induced AMPK phosphorylation and abrogated the tadalafil effect on high glucose stimulation of laminin γ1. In tadalafil-treated podocytes, we examined the interaction between H2S and nitric oxide (NO). Nω-Nitro-l-arginine methyl ester and 1H-[1,2,4]-oxadiazolo-[4,3-a]-quinoxalin-1-one, inhibitors of NO synthase (NOS) and soluble guanylyl cyclase, respectively, abolished tadalafil induction of H2S and AMPK phosphorylation. Tadalafil rapidly augmented inducible NOS (iNOS) expression by increasing its mRNA, and siRNA for iNOS and 1400W, an iNOS blocker, inhibited tadalafil stimulation of CSE expression and AMPK phosphorylation. We conclude that tadalafil amelioration of high glucose stimulation of synthesis of proteins including matrix proteins in podocytes requires integration of the NO-H2S-AMPK axis leading to the inhibition of high glucose-induced mechanistic target of rapamycin complex 1 activity and mRNA translation.
Background: The mechanism underlying tadalafil regulation of diabetes-induced matrix synthesis in the kidney is unknown.
Results: In podocytes, tadalafil stimulated inducible nitric-oxide synthase to generate hydrogen sulfide and inhibit high glucose-induced matrix protein synthesis.
Conclusion: Tadalafil recruits nitric oxide and hydrogen sulfide to inhibit high glucose-induced matrix protein synthesis.
Significance: Tadalafil may be tested for treating diabetic kidney disease.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M114.615377</identifier><identifier>PMID: 25752605</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>AMP-activated kinase (AMPK) ; AMP-Activated Protein Kinases - metabolism ; Animals ; Calcium - chemistry ; Carbolines - chemistry ; diabetes ; Diabetic Nephropathies - drug therapy ; Diabetic Nephropathies - metabolism ; Extracellular Matrix - metabolism ; fibrosis ; Gene Expression Regulation ; Glucose - chemistry ; Glycobiology and Extracellular Matrices ; Hydrogen Sulfide - chemistry ; kidney ; Kidney - cytology ; mammalian target of rapamycin (mTOR) ; Mechanistic Target of Rapamycin Complex 1 ; Mice ; Multiprotein Complexes - metabolism ; Nitric Oxide - chemistry ; Nitric Oxide Synthase Type II - antagonists & inhibitors ; Phosphodiesterase 5 Inhibitors - chemistry ; Phosphorylation ; Podocytes - cytology ; Podocytes - metabolism ; Polyribosomes - metabolism ; Rats ; Signal Transduction ; Tadalafil ; TOR Serine-Threonine Kinases - metabolism</subject><ispartof>The Journal of biological chemistry, 2015-05, Vol.290 (19), p.12014-12026</ispartof><rights>2015 © 2015 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>2015 by The American Society for Biochemistry and Molecular Biology, Inc.</rights><rights>2015 by The American Society for Biochemistry and Molecular Biology, Inc. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c489t-77e610d764a7caa2f2b649a36ae0a5c0f354786e15db7426819805db8377f4ae3</citedby><cites>FETCH-LOGICAL-c489t-77e610d764a7caa2f2b649a36ae0a5c0f354786e15db7426819805db8377f4ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424338/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424338/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25752605$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Hak Joo</creatorcontrib><creatorcontrib>Feliers, Denis</creatorcontrib><creatorcontrib>Mariappan, Meenalakshmi M.</creatorcontrib><creatorcontrib>Sataranatarajan, Kavithalakshmi</creatorcontrib><creatorcontrib>Choudhury, Goutam Ghosh</creatorcontrib><creatorcontrib>Gorin, Yves</creatorcontrib><creatorcontrib>Kasinath, Balakuntalam S.</creatorcontrib><title>Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Diabetes-induced kidney cell injury involves an increase in matrix protein expression that is only partly alleviated by current treatment, prompting a search for new modalities. We have previously shown that hydrogen sulfide (H2S) inhibits high glucose-induced protein synthesis in kidney podocytes. We tested whether tadalafil, a phosphodiesterase 5 inhibitor used to treat erectile dysfunction, ameliorates high glucose stimulation of matrix proteins by generating H2S in podocytes. Tadalafil abrogated high glucose stimulation of global protein synthesis and matrix protein laminin γ1. Tadalafil inhibited high glucose-induced activation of mechanistic target of rapamycin complex 1 and laminin γ1 accumulation in an AMP-activated protein kinase (AMPK)-dependent manner. Tadalafil increased AMPK phosphorylation by stimulating calcium-calmodulin kinase kinase β. Tadalafil rapidly increased the expression and activity of the H2S-generating enzyme cystathionine γ-lyase (CSE) by promoting its translation. dl-Propargylglycine, a CSE inhibitor, and siRNA against CSE inhibited tadalafil-induced AMPK phosphorylation and abrogated the tadalafil effect on high glucose stimulation of laminin γ1. In tadalafil-treated podocytes, we examined the interaction between H2S and nitric oxide (NO). Nω-Nitro-l-arginine methyl ester and 1H-[1,2,4]-oxadiazolo-[4,3-a]-quinoxalin-1-one, inhibitors of NO synthase (NOS) and soluble guanylyl cyclase, respectively, abolished tadalafil induction of H2S and AMPK phosphorylation. Tadalafil rapidly augmented inducible NOS (iNOS) expression by increasing its mRNA, and siRNA for iNOS and 1400W, an iNOS blocker, inhibited tadalafil stimulation of CSE expression and AMPK phosphorylation. We conclude that tadalafil amelioration of high glucose stimulation of synthesis of proteins including matrix proteins in podocytes requires integration of the NO-H2S-AMPK axis leading to the inhibition of high glucose-induced mechanistic target of rapamycin complex 1 activity and mRNA translation.
Background: The mechanism underlying tadalafil regulation of diabetes-induced matrix synthesis in the kidney is unknown.
Results: In podocytes, tadalafil stimulated inducible nitric-oxide synthase to generate hydrogen sulfide and inhibit high glucose-induced matrix protein synthesis.
Conclusion: Tadalafil recruits nitric oxide and hydrogen sulfide to inhibit high glucose-induced matrix protein synthesis.
Significance: Tadalafil may be tested for treating diabetic kidney disease.</description><subject>AMP-activated kinase (AMPK)</subject><subject>AMP-Activated Protein Kinases - metabolism</subject><subject>Animals</subject><subject>Calcium - chemistry</subject><subject>Carbolines - chemistry</subject><subject>diabetes</subject><subject>Diabetic Nephropathies - drug therapy</subject><subject>Diabetic Nephropathies - metabolism</subject><subject>Extracellular Matrix - metabolism</subject><subject>fibrosis</subject><subject>Gene Expression Regulation</subject><subject>Glucose - chemistry</subject><subject>Glycobiology and Extracellular Matrices</subject><subject>Hydrogen Sulfide - chemistry</subject><subject>kidney</subject><subject>Kidney - cytology</subject><subject>mammalian target of rapamycin (mTOR)</subject><subject>Mechanistic Target of Rapamycin Complex 1</subject><subject>Mice</subject><subject>Multiprotein Complexes - metabolism</subject><subject>Nitric Oxide - chemistry</subject><subject>Nitric Oxide Synthase Type II - antagonists & inhibitors</subject><subject>Phosphodiesterase 5 Inhibitors - chemistry</subject><subject>Phosphorylation</subject><subject>Podocytes - cytology</subject><subject>Podocytes - metabolism</subject><subject>Polyribosomes - metabolism</subject><subject>Rats</subject><subject>Signal Transduction</subject><subject>Tadalafil</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU9v3CAQxVHVqtkkPfdW8QW8ARuMfalURU02Uv5JSaXcEIaxdyIHImCj7LWfvESbRu0hXGBg3m_Ee4R85WzJmRJH94NdXnAuli2XjVIfyIKzrqkaye8-kgVjNa_6WnZ7ZD-le1aW6PlnsldLJeuWyQX5fWucmc2IMz3zGaZoMiR6iTmipVfP6KBabV0ME3h6s5nHckFvcPJmRj_RHIpqjQNmusJpTU_njQ0JKvRuY8HRC1M4z_Q6hgxYAFuf15Aw0VJcBxfstkw7JJ9GMyf48rofkF8nP2-PV9X51enZ8Y_zyoquz5VS0HLmVCuMssbUYz20ojdNa4AZadnYSKG6Frh0gxJ12_G-Y-XcFV9GYaA5IN933MfN8ADOgs_RzPox4oOJWx0M6v9fPK71FJ60ELVomq4AjnYAG0NKEcY3LWf6JQ5d4tAvcehdHEXx7d-Rb_1__S8N_a4BysefEKJOFsEX7zCCzdoFfBf-B7ycnQ4</recordid><startdate>20150508</startdate><enddate>20150508</enddate><creator>Lee, Hak Joo</creator><creator>Feliers, Denis</creator><creator>Mariappan, Meenalakshmi M.</creator><creator>Sataranatarajan, Kavithalakshmi</creator><creator>Choudhury, Goutam Ghosh</creator><creator>Gorin, Yves</creator><creator>Kasinath, Balakuntalam S.</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20150508</creationdate><title>Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes</title><author>Lee, Hak Joo ; Feliers, Denis ; Mariappan, Meenalakshmi M. ; Sataranatarajan, Kavithalakshmi ; Choudhury, Goutam Ghosh ; Gorin, Yves ; Kasinath, Balakuntalam S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c489t-77e610d764a7caa2f2b649a36ae0a5c0f354786e15db7426819805db8377f4ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>AMP-activated kinase (AMPK)</topic><topic>AMP-Activated Protein Kinases - metabolism</topic><topic>Animals</topic><topic>Calcium - chemistry</topic><topic>Carbolines - chemistry</topic><topic>diabetes</topic><topic>Diabetic Nephropathies - drug therapy</topic><topic>Diabetic Nephropathies - metabolism</topic><topic>Extracellular Matrix - metabolism</topic><topic>fibrosis</topic><topic>Gene Expression Regulation</topic><topic>Glucose - chemistry</topic><topic>Glycobiology and Extracellular Matrices</topic><topic>Hydrogen Sulfide - chemistry</topic><topic>kidney</topic><topic>Kidney - cytology</topic><topic>mammalian target of rapamycin (mTOR)</topic><topic>Mechanistic Target of Rapamycin Complex 1</topic><topic>Mice</topic><topic>Multiprotein Complexes - metabolism</topic><topic>Nitric Oxide - chemistry</topic><topic>Nitric Oxide Synthase Type II - antagonists & inhibitors</topic><topic>Phosphodiesterase 5 Inhibitors - chemistry</topic><topic>Phosphorylation</topic><topic>Podocytes - cytology</topic><topic>Podocytes - metabolism</topic><topic>Polyribosomes - metabolism</topic><topic>Rats</topic><topic>Signal Transduction</topic><topic>Tadalafil</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, Hak Joo</creatorcontrib><creatorcontrib>Feliers, Denis</creatorcontrib><creatorcontrib>Mariappan, Meenalakshmi M.</creatorcontrib><creatorcontrib>Sataranatarajan, Kavithalakshmi</creatorcontrib><creatorcontrib>Choudhury, Goutam Ghosh</creatorcontrib><creatorcontrib>Gorin, Yves</creatorcontrib><creatorcontrib>Kasinath, Balakuntalam S.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Hak Joo</au><au>Feliers, Denis</au><au>Mariappan, Meenalakshmi M.</au><au>Sataranatarajan, Kavithalakshmi</au><au>Choudhury, Goutam Ghosh</au><au>Gorin, Yves</au><au>Kasinath, Balakuntalam S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2015-05-08</date><risdate>2015</risdate><volume>290</volume><issue>19</issue><spage>12014</spage><epage>12026</epage><pages>12014-12026</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Diabetes-induced kidney cell injury involves an increase in matrix protein expression that is only partly alleviated by current treatment, prompting a search for new modalities. We have previously shown that hydrogen sulfide (H2S) inhibits high glucose-induced protein synthesis in kidney podocytes. We tested whether tadalafil, a phosphodiesterase 5 inhibitor used to treat erectile dysfunction, ameliorates high glucose stimulation of matrix proteins by generating H2S in podocytes. Tadalafil abrogated high glucose stimulation of global protein synthesis and matrix protein laminin γ1. Tadalafil inhibited high glucose-induced activation of mechanistic target of rapamycin complex 1 and laminin γ1 accumulation in an AMP-activated protein kinase (AMPK)-dependent manner. Tadalafil increased AMPK phosphorylation by stimulating calcium-calmodulin kinase kinase β. Tadalafil rapidly increased the expression and activity of the H2S-generating enzyme cystathionine γ-lyase (CSE) by promoting its translation. dl-Propargylglycine, a CSE inhibitor, and siRNA against CSE inhibited tadalafil-induced AMPK phosphorylation and abrogated the tadalafil effect on high glucose stimulation of laminin γ1. In tadalafil-treated podocytes, we examined the interaction between H2S and nitric oxide (NO). Nω-Nitro-l-arginine methyl ester and 1H-[1,2,4]-oxadiazolo-[4,3-a]-quinoxalin-1-one, inhibitors of NO synthase (NOS) and soluble guanylyl cyclase, respectively, abolished tadalafil induction of H2S and AMPK phosphorylation. Tadalafil rapidly augmented inducible NOS (iNOS) expression by increasing its mRNA, and siRNA for iNOS and 1400W, an iNOS blocker, inhibited tadalafil stimulation of CSE expression and AMPK phosphorylation. We conclude that tadalafil amelioration of high glucose stimulation of synthesis of proteins including matrix proteins in podocytes requires integration of the NO-H2S-AMPK axis leading to the inhibition of high glucose-induced mechanistic target of rapamycin complex 1 activity and mRNA translation.
Background: The mechanism underlying tadalafil regulation of diabetes-induced matrix synthesis in the kidney is unknown.
Results: In podocytes, tadalafil stimulated inducible nitric-oxide synthase to generate hydrogen sulfide and inhibit high glucose-induced matrix protein synthesis.
Conclusion: Tadalafil recruits nitric oxide and hydrogen sulfide to inhibit high glucose-induced matrix protein synthesis.
Significance: Tadalafil may be tested for treating diabetic kidney disease.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25752605</pmid><doi>10.1074/jbc.M114.615377</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 2015-05, Vol.290 (19), p.12014-12026 |
issn | 0021-9258 1083-351X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4424338 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | AMP-activated kinase (AMPK) AMP-Activated Protein Kinases - metabolism Animals Calcium - chemistry Carbolines - chemistry diabetes Diabetic Nephropathies - drug therapy Diabetic Nephropathies - metabolism Extracellular Matrix - metabolism fibrosis Gene Expression Regulation Glucose - chemistry Glycobiology and Extracellular Matrices Hydrogen Sulfide - chemistry kidney Kidney - cytology mammalian target of rapamycin (mTOR) Mechanistic Target of Rapamycin Complex 1 Mice Multiprotein Complexes - metabolism Nitric Oxide - chemistry Nitric Oxide Synthase Type II - antagonists & inhibitors Phosphodiesterase 5 Inhibitors - chemistry Phosphorylation Podocytes - cytology Podocytes - metabolism Polyribosomes - metabolism Rats Signal Transduction Tadalafil TOR Serine-Threonine Kinases - metabolism |
title | Tadalafil Integrates Nitric Oxide-Hydrogen Sulfide Signaling to Inhibit High Glucose-induced Matrix Protein Synthesis in Podocytes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T08%3A32%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tadalafil%20Integrates%20Nitric%20Oxide-Hydrogen%20Sulfide%20Signaling%20to%20Inhibit%20High%20Glucose-induced%20Matrix%20Protein%20Synthesis%20in%20Podocytes&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Lee,%20Hak%20Joo&rft.date=2015-05-08&rft.volume=290&rft.issue=19&rft.spage=12014&rft.epage=12026&rft.pages=12014-12026&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M114.615377&rft_dat=%3Cpubmed_cross%3E25752605%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/25752605&rft_els_id=S0021925820485114&rfr_iscdi=true |